The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of pacritinib on symptoms in with thrombocytopenia and myelofibrosis who require red blood cell transfusion.
 
Stephen Oh
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; Cogent Biosciences; Constellation Pharmaceuticals; CTI BioPharma Corp; Geron; Incyte; Protagonist Therapeutics; Sierra Oncology
Research Funding - Actuate Therapeutics (Inst); Blueprint Medicines (Inst); Bristol-Myers Squibb/Celgene (Inst); Cogent Biosciences (Inst); Constellation Pharmaceuticals (Inst); CTI (Inst); Incyte (Inst); Ionis Pharmaceuticals (Inst); Kartos Therapeutics (Inst); Pharmaessentia (Inst); Sierra Oncology (Inst); Takeda (Inst)
 
James K. McCloskey
Stock and Other Ownership Interests - COTA
Consulting or Advisory Role - Abbvie; Amgen; Astex Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Stemline Therapeutics; Takeda
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Incyte; SOBI; Stemline Therapeutics; Takeda
Research Funding - Stemline Therapeutics
 
Marta Sobas
Travel, Accommodations, Expenses - CTI BioPharma Corp
 
Sarah Buckley
Employment - CTI BioPharma Corp; SOBI
Stock and Other Ownership Interests - CTI BioPharma Corp
 
Purvi Suthar
Employment - CTI BioPharma Corp; SOBI
Stock and Other Ownership Interests - CTI BioPharma Corp
 
Karisse Roman-Torres
Stock and Other Ownership Interests - CTI BioPharma Corp
Consulting or Advisory Role - CTI BioPharma Corp; SOBI
 
Aaron Thomas Gerds
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb/Celgene; CTI; GlaxoSmithKline/Sierra Oncology; Imago Pharma; Kartos Therapeutics; MorphoSys; Pharmaessentia; Rain Therapeutics
Research Funding - Celgene; CTI; Gilead Sciences; Incyte; Pfizer; Roche/Genentech